Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -0.102\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CC(=O)Nc1csc2ccccc12
b. CCOc1ccccc1C(=O)NCC(=O)OCCCOC(=O)CNC(=O)c1ccccc1OCC
c. Cc1ccnc(N2CCN(c3cc(C)c(C#N)c4nc5ccccc5n34)CC2)c1
d. COc1cc(OC)cc(-c2c(-c3cccs3)c3cc(-c4ccc(OC)nc4)ccc3n2C)c1
e. CCN1CCN(Cc2ccc(NC(=O)c3cc(NC(=O)N4CCNC4=O)cc(OC)c3)cc2C(F)(F)F)CC1
Answer: c. Cc1ccnc(N2CCN(c3cc(C)c(C#N)c4nc5ccccc5n34)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccnc(N2CCN(c3cc(C)c(C#N)c4nc5ccccc5n34)CC2)c1
Cc1ccnc(N2CCN(c3cc(C)c(C#N)c4nc5ccccc5n34)CC2)c1
3-methyl-1-[4-(4-methylpyridin-2-yl)piperazin-1-yl]pyrido[1,2-a]benzimidazole-4-carbonitrile